Protective effect of sevoflurane preconditioning on ischemia-reperfusion injury in patients undergoing reconstructive plastic surgery with microsurgical flap, a randomized controlled trial
Open Access
- 1 December 2015
- journal article
- research article
- Published by Springer Nature in BMC Anesthesiology
- Vol. 16 (1) , 66
Abstract
In many clinical conditions that involve free flaps and tissue transplantations the possibility of minimizing ischemia-reperfusion injury can be a determinant factor for the success of the surgery itself. We hypothesize that preconditioning with sevoflurane is a protective factor against ischemia-reperfusion injury. In this randomized controlled trial, patients ASA I-II undergoing breast reconstruction with deep inferior epigastric perforator flaps were allocated into two groups and analyzed: group BAL included patients who received balanced anesthesia with sevoflurane for 30 min before removal of the flap and throughout the surgery. The TCI group included patients who received a total intravenous anesthesia with propofol and remifentanil. We evaluated regional tissue oximetry at the end of the surgery and at 4, 12 and 20 h after surgery. Other assessed parameters were: blood lactate clearance, alanine aminotransferase, aspartate aminotransferase, lactic dehydrogenase, creatine phosphokinase. In total 54 patients, twenty-seven per group, were analyzed. There was a significant increase of the average value of regional tissue oximetry measured 4 h after surgery in the BAL group compared to the TCI group: BAL: 84.05 % (8.96 SD); TCI : 76.17 % (12.92 SD) (P = 0.03), but not at the other time frames. The creatine phosphokinase value was significantly lower in the BAL group at the end of surgery, but not at the other time-frames. There were no significant differences in blood levels of other markers. From our results, the positive preconditioning impact of sevoflurane on ischemia-reperfusion injury in patients undergoing free flap surgery is expressed in the early postoperative hours, but it does not persist in the long-term. ClinicalTrial.gov identifier: NCT01905501 . Registered July 18, 2013Keywords
This publication has 41 references indexed in Scilit:
- Update on Ischemia-Reperfusion Injury for the Plastic SurgeonPlastic and Reconstructive Surgery, 2011
- Roles of the nitric oxide signaling pathway in cardiac ischemic preconditioning against myocardial ischemia-reperfusion injuryMedical Science Monitor, 2011
- Sevoflurane preconditioning confers neuroprotection via anti-inflammatory effectsFrontiers in Bioscience-Elite, 2011
- Gender Differences in Endothelial Progenitor Cells and Cardiovascular Risk ProfileArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Sevoflurane Inhalation at Sedative Concentrations Provides Endothelial Protection against Ischemia–Reperfusion Injury in HumansAnesthesiology, 2007
- Gender-Specificity of Delayed Preconditioning by Isoflurane in Rabbits: Potential Role of Endothelial Nitric Oxide SynthaseAnesthesia & Analgesia, 2006
- Effect of sevoflurane preconditioning on ischaemia/reperfusion injury in the rat kidney in vivoEuropean Journal of Anaesthesiology, 2006
- Remote ischemic preconditioning of flaps: A reviewMicrosurgery, 2005
- Preconditioning with Isoflurane Produces Dose-Dependent Neuroprotection via Activation of Adenosine Triphosphate-Regulated Potassium Channels After Focal Cerebral Ischemia in RatsAnesthesia & Analgesia, 2003
- Preconditioning with Isoflurane Produces Dose-Dependent Neuroprotection via Activation of Adenosine Triphosphate-Regulated Potassium Channels After Focal Cerebral Ischemia in RatsAnesthesia & Analgesia, 2003